In this blog post, we take a look at the latest happenings around medical devices for cardiovascular disease management.
Abbott’s FILVAS Gets Breakthrough Designation
The FDA has awarded Abbott’s Fully Implantable Left Ventricular Assist System (FILVAS) a “Breakthrough Device Designation”. FILVAS builds on the HeartMate 3 Left Ventricular Assist Device (LVAD) technology. FILVAS will give people living with a LVAD meaningful periods of time when they are completely untethered and need not carry any external equipment. To read more, click here.
Medtronic Receives EU’s CE Approval for Next-gen ICDs, CRT-Ds
Medtronic’s Cobalt and Crome implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds) won the CE approval mark from the European Union. Medtronic is reportedly launching its TriageHF tech in conjunction with the Cobalt and Crome platforms. To read more, click here.
MIT Researchers Create a Bionic Heart to Aid Medical Device Makers
Engineers at MIT have developed a bionic heart designed to offer a more realistic model for testing artificial valves and other medical devices. The model device is expected to reduce the developmental costs associated with new cardiac devices by allowing engineers to fine-tune their design and decreasing the need for animal tests. To read more, click here.
To learn more about hypertension management devices, click here.
To learn more about MaxVal’s Search and Analytics services, click here.